234 related articles for article (PubMed ID: 37392233)
1. Deep learning-assisted LI-RADS grading and distinguishing hepatocellular carcinoma (HCC) from non-HCC based on multiphase CT: a two-center study.
Xu Y; Zhou C; He X; Song R; Liu Y; Zhang H; Wang Y; Fan Q; Chen W; Wu J; Wang J; Guo D
Eur Radiol; 2023 Dec; 33(12):8879-8888. PubMed ID: 37392233
[TBL] [Abstract][Full Text] [Related]
2. Deep learning LI-RADS grading system based on contrast enhanced multiphase MRI for differentiation between LR-3 and LR-4/LR-5 liver tumors.
Wu Y; White GM; Cornelius T; Gowdar I; Ansari MH; Supanich MP; Deng J
Ann Transl Med; 2020 Jun; 8(11):701. PubMed ID: 32617321
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of treatment response in hepatocellular carcinoma in the explanted liver with Liver Imaging Reporting and Data System version 2017.
Seo N; Kim MS; Park MS; Choi JY; Do RKG; Han K; Kim MJ
Eur Radiol; 2020 Jan; 30(1):261-271. PubMed ID: 31418085
[TBL] [Abstract][Full Text] [Related]
4. Intraindividual Comparison of Contrast-Enhanced Ultrasound Using Perfluorobutane With Modified Criteria Versus CT/MRI LI-RADS Version 2018 for Diagnosing HCC in High-Risk Patients.
Li L; Mao S; Wang J; Zheng W; Shen J; Clevert DA; Zhou J
AJR Am J Roentgenol; 2023 May; 220(5):682-691. PubMed ID: 36382914
[No Abstract] [Full Text] [Related]
5. LI-RADS-CEUS - Proposal for a Contrast-Enhanced Ultrasound Algorithm for the Diagnosis of Hepatocellular Carcinoma in High-Risk Populations.
Schellhaas B; Wildner D; Pfeifer L; Goertz RS; Hagel A; Neurath MF; Strobel D
Ultraschall Med; 2016 Dec; 37(6):627-634. PubMed ID: 27486793
[No Abstract] [Full Text] [Related]
6. Automated CT LI-RADS v2018 scoring of liver observations using machine learning: A multivendor, multicentre retrospective study.
Mulé S; Ronot M; Ghosn M; Sartoris R; Corrias G; Reizine E; Morard V; Quelever R; Dumont L; Hernandez Londono J; Coustaud N; Vilgrain V; Luciani A
JHEP Rep; 2023 Oct; 5(10):100857. PubMed ID: 37771548
[TBL] [Abstract][Full Text] [Related]
7. Performance of LI-RADS Version 2018 on CT for Determining Eligibility for Liver Transplant According to Milan Criteria in Patients at High Risk for Hepatocellular Carcinoma.
Bae JS; Lee DH; Lee SM; Suh KS; Lee KW; Yi NJ; Lee KB; Kim H; Han JK
AJR Am J Roentgenol; 2022 Jul; 219(1):86-96. PubMed ID: 35138137
[No Abstract] [Full Text] [Related]
8. Assessment of primary liver carcinomas other than hepatocellular carcinoma (HCC) with LI-RADS v2018: comparison of the LI-RADS target population to patients without LI-RADS-defined HCC risk factors.
Fraum TJ; Cannella R; Ludwig DR; Tsai R; Naeem M; LeBlanc M; Salter A; Tsung A; Shetty AS; Borhani AA; Furlan A; Fowler KJ
Eur Radiol; 2020 Feb; 30(2):996-1007. PubMed ID: 31654212
[TBL] [Abstract][Full Text] [Related]
9. Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1,006 nodules.
Terzi E; Iavarone M; Pompili M; Veronese L; Cabibbo G; Fraquelli M; Riccardi L; De Bonis L; Sangiovanni A; Leoni S; Zocco MA; Rossi S; Alessi N; Wilson SR; Piscaglia F;
J Hepatol; 2018 Mar; 68(3):485-492. PubMed ID: 29133247
[TBL] [Abstract][Full Text] [Related]
10. Hepatocellular carcinoma (HCC) versus non-HCC: accuracy and reliability of Liver Imaging Reporting and Data System v2018.
Ludwig DR; Fraum TJ; Cannella R; Ballard DH; Tsai R; Naeem M; LeBlanc M; Salter A; Tsung A; Shetty AS; Borhani AA; Furlan A; Fowler KJ
Abdom Radiol (NY); 2019 Jun; 44(6):2116-2132. PubMed ID: 30798397
[TBL] [Abstract][Full Text] [Related]
11. LI-RADS v2017 categorisation of HCC using CT: Does moderate to severe fatty liver affect accuracy?
Kim SS; Hwang JA; Shin HC; Choi SY; Kang TW; Jou SS; Lee WH; Park S; Heo NH
Eur Radiol; 2019 Jan; 29(1):186-194. PubMed ID: 30073499
[TBL] [Abstract][Full Text] [Related]
12. Deep learning-assisted differentiation of pathologically proven atypical and typical hepatocellular carcinoma (HCC) versus non-HCC on contrast-enhanced MRI of the liver.
Oestmann PM; Wang CJ; Savic LJ; Hamm CA; Stark S; Schobert I; Gebauer B; Schlachter T; Lin M; Weinreb JC; Batra R; Mulligan D; Zhang X; Duncan JS; Chapiro J
Eur Radiol; 2021 Jul; 31(7):4981-4990. PubMed ID: 33409782
[TBL] [Abstract][Full Text] [Related]
13. Contrast-enhanced ultrasound Liver Imaging Reporting and Data System: Lights and shadows in hepatocellular carcinoma and cholangiocellular carcinoma diagnosis.
Vidili G; Arru M; Solinas G; Calvisi DF; Meloni P; Sauchella A; Turilli D; Fabio C; Cossu A; Madeddu G; Babudieri S; Zocco MA; Iannetti G; Di Lembo E; Delitala AP; Manetti R
World J Gastroenterol; 2022 Jul; 28(27):3488-3502. PubMed ID: 36158272
[TBL] [Abstract][Full Text] [Related]
14. Development of a deep-learning model for classification of LI-RADS major features by using subtraction images of MRI: a preliminary study.
Park J; Bae JS; Kim JM; Witanto JN; Park SJ; Lee JM
Abdom Radiol (NY); 2023 Aug; 48(8):2547-2556. PubMed ID: 37222771
[TBL] [Abstract][Full Text] [Related]
15. Expanding the Liver Imaging Reporting and Data System (LI-RADS) v2018 diagnostic population: performance and reliability of LI-RADS for distinguishing hepatocellular carcinoma (HCC) from non-HCC primary liver carcinoma in patients who do not meet strict LI-RADS high-risk criteria.
Ludwig DR; Fraum TJ; Cannella R; Tsai R; Naeem M; LeBlanc M; Salter A; Tsung A; Fleckenstein J; Shetty AS; Borhani AA; Furlan A; Fowler KJ
HPB (Oxford); 2019 Dec; 21(12):1697-1706. PubMed ID: 31262487
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the accuracy of AASLD and LI-RADS criteria for the non-invasive diagnosis of HCC smaller than 3 cm.
Ronot M; Fouque O; Esvan M; Lebigot J; Aubé C; Vilgrain V
J Hepatol; 2018 Apr; 68(4):715-723. PubMed ID: 29274407
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic Accuracy of CEUS LI-RADS for the Characterization of Liver Nodules 20 mm or Smaller in Patients at Risk for Hepatocellular Carcinoma.
Huang JY; Li JW; Lu Q; Luo Y; Lin L; Shi YJ; Li T; Liu JB; Lyshchik A
Radiology; 2020 Feb; 294(2):329-339. PubMed ID: 31793849
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic Performance of the 2018 EASL vs. LI-RADS for Hepatocellular Carcinoma Using CT and MRI: A Systematic Review and Meta-Analysis of Comparative Studies.
Shin J; Lee S; Yoon JK; Roh YH
J Magn Reson Imaging; 2023 Dec; 58(6):1942-1950. PubMed ID: 37010244
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic Performance of Modified Contrast-Enhanced Ultrasound Liver Imaging Reporting and Data System in Patients Without Risk Factors for Hepatocellular Carcinoma: Comparison With World Federation for Ultrasound in Medicine and Biology Guideline.
Zhang Y; Li Q; Li L; Hong Y; Qiang B; Yu Y; Guo R; Deng H; Han X; Zou X; Guo Z; Zhou J
Ultrasound Med Biol; 2024 Feb; 50(2):243-250. PubMed ID: 37985306
[TBL] [Abstract][Full Text] [Related]
20. Contrast-enhanced ultrasound LI-RADS 2017: comparison with CT/MRI LI-RADS.
Ding J; Long L; Zhang X; Chen C; Zhou H; Zhou Y; Wang Y; Jing X; Ye Z; Wang F
Eur Radiol; 2021 Feb; 31(2):847-854. PubMed ID: 32803416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
